The CSF level of NSE has also been studied in neurodegenerative disorders, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Lewy body disease (LBD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). This evidence concerns the gene ENO2 and Parkinson disease.